Diltiazem used as a tacrolimus-sparing agent for treatment of pediatric patients with refractory nephrotic syndrome: a case report and retrospective analysis - Sun, Jie-Yu; Hu, Ya-Hui; Guo, Hong-Li; Jing, Xia; Xu, Ze-Jun; Sun, Fang; Guo, Hui-Lei; Ding, Xuan-Sheng; Chen, Feng; Xu, Jing (European journal of clinical pharmacology, 2019)
Keywords: Biomedical and Life Sciences; Biomedicine; Child; Child, Preschool; Cytochrome P-450 CYP3A - genetics; Cytochrome P-450 CYP3A - metabolism; Diltiazem; Diltiazem - pharmacology; Diltiazem - therapeutic use; Drug Interactions; Drug Resistance - genetics; Female; Glucocorticoids - pharmacology; Glucocorticoids - therapeutic use; Humans; Immunosuppressive Agents - pharmacology; Immunosuppressive Agents - therapeutic use; Letter to the Editor; Male; Nephrotic syndrome; Nephrotic Syndrome - diagnosis; Nephrotic Syndrome - drug therapy; Nephrotic Syndrome - pathology; Pharmacology/Toxicology; Retrospective Studies; Tacrolimus; Tacrolimus - pharmacology; Tacrolimus - therapeutic use; Treatment Outcome